Product Information
LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.0289 per EA under NDC 43547042050. Its NADAC has been published 417 times since Aug 29, 2018.
FDA first approved this application on Jul 1, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB
Lisinopril and Hydrochlorothiazide TabletsStrength
12.5; 10 mg/1; mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547042050
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LISINOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA076230FDA Approved
7/1/2002
TE Code
AB
On Market Since
3/12/2015
Pharmacological Classes
Price Statistics
The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has been published 417 times since Aug 29, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0289 per EA |
|---|---|
| All-time high | $0.0407 (Aug 11, 2021) |
| All-time low | $0.0241 (Nov 20, 2024) |
| 52-week high | $0.0307 |
| 52-week low | $0.0284 |
| Median price | $0.0334 |
| Average price | $0.0335 |
| Largest weekly change | +41.0% (May 22, 2019) |
| Weeks tracked | 417 |
| Tracking since | Aug 29, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB, manufactured by Solco Healthcare US LLC, is $0.0289 per EA (NDC 43547042050), effective Aug 19, 2026.
How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has held within roughly two percent of its current level. It has been tracked across 417 weekly CMS publications since Aug 29, 2018.
What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
Since Aug 29, 2018, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has ranged from a low of $0.0241 (Nov 20, 2024) to a high of $0.0407 (Aug 11, 2021), with a median of $0.0334 per EA.
Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB (NDC 43547042050) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.